antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes. Mol. Cancer Ther., 8, 2276–2285. 20. Guenin,S., Mauriat,M., Pelloux,J., Van Wuytswinkel,O., Bellini,C. and Gutierrez,L. (2009) Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions- speciﬁc, validation of references. J. Exp. Bot., 60, 487–493. 21. Hackel,B.J., Kapila,A. and Wittrup,K.D. (2008) Picomolar aﬃnity ﬁbronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuﬄing. J. Mol. Biol., 381, 1238–1252. 22. Faltus,T., Yuan,J., Zimmer,B., Kramer,A., Loibl,S., Kaufmann,M. and Strebhardt,K. (2004) Silencing of the HER2/ neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. Neoplasia, 6, 786–795. 23. Choudhury,A., Charo,J., Parapuram,S.K., Hunt,R.C., Hunt,D.M., Seliger,B. and Kiessling,R. (2004) Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. Int. J. Cancer, 108, 71–77. 24. Blackburn,P., Wilson,G. and Moore,S. (1977) Ribonuclease inhibitor from human placenta. Puriﬁcation and properties. J. Biol. Chem., 252, 5904–5910. 25. Rana,T.M. (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol., 8, 23–36. 26. Duchardt,F., Fotin-Mleczek,M., Schwarz,H., Fischer,R. and Brock,R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traﬃc, 8, 848–866. 27. Wang,T., Zhao,J., Ren,J.L., Zhang,L., Wen,W.H., Zhang,R., Qin,W.W., Jia,L.T., Yao,L.B., Zhang,Y.Q. et al. (2007) Recombinant immunoproapoptotic proteins with furin site can translocate and kill HER2-positive cancer cells. Cancer Res., 67, 11830–11839. 28. Manikandan,J., Pushparaj,P.N. and Melendez,A.J. (2007) Protein i: interference at protein level by intrabodies. Front Biosci., 12, 1344–1352. 29. Tanaka,T., Williams,R.L. and Rabbitts,T.H. (2007) Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS. Embo J., 26, 3250–3259. 30. Ye,J.D., Tereshko,V., Frederiksen,J.K., Koide,A., Fellouse,F.A., Sidhu,S.S., Koide,S., Kossiakoﬀ,A.A. and Piccirilli,J.A. (2008) Nucleic Acids Research, 2010, Vol. 38, No. 5 1609 Synthetic antibodies for speciﬁc recognition and crystallization of structured RNA. Proc. Natl Acad. Sci. USA, 105, 82–87. 31. Bobeck,M.J., Rueda,D., Walter,N.G. and Glick,G.D. (2007) Structural modeling of sequence speciﬁcity by an autoantibody against single-stranded DNA. Biochemistry, 46, 6753–6765. 32. Cerutti,M.L., Centeno,J.M., Goldbaum,F.A. and de Prat-Gay,G. (2001) Generation of sequence-speciﬁc, high aﬃnity anti-DNA antibodies. J. Biol. Chem., 276, 12769–12773. 33. Mandell,J.G. and Barbas,C.F. 3rd. (2006) Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res., 34, W516–W523. 34. Auweter,S.D., Oberstrass,F.C. and Allain,F.H. (2006) Sequence-speciﬁc binding of single-stranded RNA: is there a code for recognition? Nucleic Acids Res., 34, 4943–4959. 35. Lustig,B., Arora,S. and Jernigan,R.L. (1997) RNA base-amino acid interaction strengths derived from structures and sequences. Nucleic Acids Res., 25, 2562–2565. 36. Yanase,K. and Madaio,M.P. (2005) Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53. J. Autoimmun., 24, 145–151. 37. Kozyr,A.V., Sashchenko,L.P., Kolesnikov,A.V., Zelenova,N.A., Khaidukov,S.V., Ignatova,A.N., Bobik,T.V., Gabibov,A.G., Alekberova,Z.S., Suchkov,S.V. et al. (2002) Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol. Lett., 80, 41–47. 38. Rivadeneyra-Espinoza,L. and Ruiz-Arguelles,A. (2006) Cell- penetrating anti-native DNA antibodies trigger apoptosis through both the neglect and programmed pathways. J. Autoimmun., 26, 52–56. 39. Ruiz-Arguelles,A., Rivadeneyra-Espinoza,L. and Alarcon-Segovia,D. (2003) Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications. Curr. Pharm. Des., 9, 1881–1887. 40. Avrameas,A., Gasmi,L. and Buttin,G. (2001) DNA and heparin alter the internalization process of anti-DNA monoclonal antibodies according to patterns typical of both the charged molecule and the antibody. J. Autoimmun., 16, 383–391. 41. Zack,D.J., Stempniak,M., Wong,A.L., Taylor,C. and Weisbart,R.H. (1996) Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J. Immunol., 157, 2082–2088.